导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.04% | 132/348 |
| 近一周 | -2.16% | 158/354 |
| 近一月 | -4.15% | 218/354 |
| 近一季 | -6.48% | 246/354 |
| 近半年 | 15.17% | 112/350 |
| 近一年 | 11.53% | 131/343 |
| 近两年 | 35.77% | 138/308 |
| 近三年 | 69.30% | 51/242 |
| 成立以来 | 211.23% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.61% 237/360 |
25.03% 52/366 |
- - |
- - |
| 2025 | 15.22% 229/358 |
-8.87% 300/340 |
16.59% 54/348 |
7.62% 200/354 |
0.76% 150/358 |
| 2024 | 24.32% 51/329 |
8.11% 70/280 |
8.01% 59/310 |
-0.01% 251/318 |
6.48% 44/329 |
| 2023 | 53.82% 12/275 |
18.40% 25/205 |
20.21% 20/230 |
-3.72% 91/262 |
12.26% 56/276 |
| 2022 | -28.43% 136/201 |
-8.89% 71/153 |
-19.87% 142/164 |
0.18% 37/189 |
-2.15% 171/202 |
| 2021 | 24.33% 26/150 |
2.18% 128/312 |
9.65% 67/328 |
1.48% 34/358 |
9.35% 32/151 |
| 2020 | 34.14% 20/103 |
-11.00% 136/280 |
29.54% 40/295 |
7.93% 69/299 |
7.80% 161/305 |
| 2019 | 39.37% 5/88 |
14.35% 56/258 |
6.07% 17/267 |
3.66% 49/253 |
10.85% 53/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 广发纳斯达克100ETF联接人民币(QDII)C VS. 建信富时100指数(QDII)人民币A(539003) |